Back to Newsroom
Back to Newsroom

Chemiluminescence Immunoassay (CLIA) Analyzers Market to Rise at CAGR of 6.3% during Forecast Period: TMR Study

Thursday, 01 September 2022 01:33 PM

WILMINGTON, DE / ACCESSWIRE / September 1, 2022 / Transparency Market Research Inc. - As per a TMR Study, the value of global chemiluminescence immunoassay (CLIA) analyzers market stood at US$ 5.04 Bn in 2018. The global market is expected to develop at 6.3% CAGR during the forecast period, from 2019 to 2027. The prevalence of chronic diseases has risen over time as a result of expanding ageing population. Additionally, body mass index or BMI and smoking, which are well-recognized risk factors for various chronic illnesses including cardiovascular disease, cancer, are expected to drive the expansion of the market.

Transparency Market Research inc., Thursday, September 1, 2022, Press release picture

The market for chemiluminescence immunoassay (CLIA) analyzers is dominated by pathologists and physicians who work in out-patient and in-patient settings. One of their main goals is to increase the pace at which the tests are standardized. Calibration of the assays is done primarily for the purpose of comparing the test findings to accepted standards before giving those to the patients.

The closed system multiplexed automated analyzers used in CLIA devices have a large throughput. The calibration of these systems is not too difficult and it is one of the important ongoing trends of the chemiluminescence immunoassay (CLIA) analyzers. The CLIA analyzers are produced in accordance with standards established by regulatory bodies. In order to improve the comparability of their results with those from other manual assay techniques, the CLIA test makers additionally provide internal reference standard material. The future market demand for chemiluminescence immunoassay (CLIA) analyzers is thus projected to be driven by rising requirement of international accreditations as well as result comparability employing high throughput automated immunoassays.

Get Exclusive PDF Sample Copy of Chemiluminescence Immunoassay (CLIA) Analyzers Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31517

The global market for chemiluminescence immunoassay (CLIA) analyzers is expected to grow as industry participants spend more on research and development initiatives to create and promote new products. Increasing spending on R&D activities is likely to emerge as recent developments in the chemiluminescence immunoassay (CLIA) analyzers.

Key Findings of Market Report

  • The advent of next-generation integrated immunoassays is a significant technological development seen in the global market for chemiluminescence immunoassay analyzers. Consider the Alinity ci-series of equipment for clinical chemistry and immunoassay diagnostics, which Abbott announced on October 31, 2017, received FDA 510(k) approval. The development of multiplexed assays is anticipated to boost the global CLIA analyzers market throughout the course of the projection.
  • In addition, leading players in the chemiluminescence immunoassay (CLIA) analyzers market are actively expanding their product test portfolio via ongoing R&D activities. The demand for ongoing research by both recognized and new companies with the goal of expanding their test portfolio is projected to lead to growth of the global chemiluminescence immunoassay (CLIA) analyzers market.
  • Market participants are focused on obtaining regulatory clearances, developing technologically cutting-edge products, introducing new products, and partnering and acquiring other businesses. These tactics are probably going to drive the global market for chemiluminescence immunoassay (CLIA) analyzers.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=31517

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market: Key Players

Some of the key market players are

  • DiaSorin S.p.A
  • Shenzhen New Industries Biomedical Engineering Co., Ltd
  • F. Hoffmann-La Roche Ltd
  • Randox Laboratories Ltd
  • Ortho Clinical Diagnostics (Part of Carlyle Group)
  • Tosoh Corporation

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market: Segmentation

Product Type

  • Analyzers
  • Reagents
  • Consumables

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=31517

Application

  • Endocrine Disorders
  • Oncology
  • Infectious Diseases
  • Hepatitis and Retrovirus
  • Cardiovascular Disorders
  • Allergy
  • Autoimmunity
  • Drug Discovery & Development
  • Others

End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Industries
  • Others

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Atopic Dermatitis Drugs Market: The global atopic dermatitis drugs market is anticipated to reach more than US$ 29.4 Bn by the end of 2031 with a CAGR of 14.7% from 2022 to 2031.

Skincare Serums Market: The global skincare serum market is anticipated to reach more than US$ 6.28 Bn by the end of 2031 with a CAGR of 7.4% from 2022 to 2031

Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031 with a CAGR of 5.6% from 2022 to 2031

Equine Supplement Products Market: The global equine supplement products market is anticipated to reach US$ 111 Mn by the end of 2031 with a CAGR of 3.7% from 2022 to 2031

Epilepsy Therapeutics Market: The global epilepsy therapeutics market is anticipated to reach more than US$ 14.9 Bn by the end of 2031 with a CAGR of 3.5% from 2022 to 2031

Post-operative Pain Therapeutics Market: The global post-operative pain therapeutics market is anticipated to reach more than US$ 22.3 Bn by the end of 2031 with a CAGR of 5.7% from 2022 to 2031

Joint Pain Injections Market: The global joint pain injections market is anticipated to reach more than US$ 9.8 Bn by the end of 2031 with a CAGR of 7.8% from 2022 to 2031

Human Microbiome Market: The human microbiome market in India is anticipated to reach more than US$ 282 Mn by the end of 2031 with a CAGR of 6.9% from 2022 to 2031

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]

SOURCE: Transparency Market Research inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: